Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779 (Q33305157)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779 |
scientific article |
Statements
1 reference
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779 (English)
1 reference
Michael P Messina
1 reference
Aubrey Rauktys
1 reference
Laifong Lee
1 reference
Sandra L Dabora
1 reference
6 November 2007
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference